ASAP1 and liver cancer: As summarized in Table 1, higher levels of ASAP1-IT1 expression were significantly associated with higher Barcelona Clinic Liver Cancer (BCLC) stages (p = 0.028), a greater number of satellite nodules (p = 0.027), and poorer pathological differentiation (p = 0.013).